Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
N-acetyl-L-Glutamic acid (NAG) is an endogenous metabolite.1 It is an allosteric activator of mitochondrial carbamoyl phosphate synthetase, an enzyme involved in the urea cycle, and the first intermediate in arginine biosynthesis in bacteria.2,3,4 NAG inhibits human liver NAG synthase (NAGS; Ki = 0.25 mM).5 It also inhibits several enzymes involved in mitochondrial bioenergetics, including isocitrate dehydrogenase 2 (IDH2), mitochondrial complex IV, also known as cytochrome c oxidase, and glutamate dehydrogenase (GDH), in rat brain mitochondrial preparations when used at a concentration of 1 mM.6 Increased urine levels of NAG are associated with mutations in the gene encoding aminoacylase-1 (ACY1), an enzyme involved in the hydrolysis of N-acetylated proteins.1
WARNING This product is not for human or veterinary use.
1. Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am. J. Hum. Genet. 78(3), 401-409 (2006).
2. Binding of N-
3. Physical and kinetic properties of carbamyl phosphate synthetase from frog liver. The Journal of Biological Chemisty 236(8), 2229-2237 (1961).
4. A novel type of N-
5. N-
6. N-